The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Nitidine ID: ALA176008
Cas Number: 6872-57-7
PubChem CID: 4501
Product Number: N693349, Order Now?
Max Phase: Preclinical
Molecular Formula: C21H18NO4+
Molecular Weight: 348.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms from Alternative Forms(1): NSC-146397
Canonical SMILES: COc1cc2c[n+](C)c3c4cc5c(cc4ccc3c2cc1OC)OCO5
Standard InChI: InChI=1S/C21H18NO4/c1-22-10-13-7-17(23-2)18(24-3)8-15(13)14-5-4-12-6-19-20(26-11-25-19)9-16(12)21(14)22/h4-10H,11H2,1-3H3/q+1
Standard InChI Key: KKMPSGJPCCJYRV-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
8.0295 -14.3379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7384 -14.7348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2996 -14.7348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0295 -13.5111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4590 -14.3379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7384 -15.5616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2996 -15.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5839 -14.3379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7384 -13.1093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4590 -13.5111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1653 -14.7255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0295 -15.9609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4494 -15.9468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5839 -15.9609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8610 -14.7348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1653 -13.1093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9071 -14.3568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8610 -15.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1569 -14.3381 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9071 -13.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6773 -14.5671 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1569 -15.9468 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1569 -13.5301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6773 -13.2748 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1591 -13.9291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4578 -15.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 3 1 0
1 4 1 0
2 5 1 0
2 6 1 0
3 7 2 0
3 8 1 0
4 9 2 0
5 10 2 0
5 11 1 0
6 12 2 0
6 13 1 0
7 14 1 0
8 15 2 0
10 16 1 0
11 17 2 0
14 18 2 0
15 19 1 0
16 20 2 0
17 21 1 0
18 22 1 0
19 23 1 0
20 24 1 0
21 25 1 0
22 26 1 0
7 12 1 0
9 10 1 0
15 18 1 0
17 20 1 0
24 25 1 0
M CHG 1 6 1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 348.38Molecular Weight (Monoisotopic): 348.1230AlogP: 3.72#Rotatable Bonds: 2Polar Surface Area: 40.80Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: -0.88CX LogD: -0.88Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.41Np Likeness Score: 0.87
References 1. Cheng P, Zhou J, Qing Z, Kang W, Liu S, Liu W, Xie H, Zeng J.. (2014) Synthesis of 5-methyl phenanthridium derivatives: a new class of human DOPA decarboxylase inhibitors., 24 (12): [PMID:24794108 ] [10.1016/j.bmcl.2014.04.047 ] 2. Swain SS, Pati S, Hussain T.. (2022) Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation., 232 [PMID:35168150 ] [10.1016/j.ejmech.2022.114173 ] 3. Mishra SK, Tripathi G, Kishore N, Singh RK, Singh A, Tiwari VK.. (2017) Drug development against tuberculosis: Impact of alkaloids., 137 [PMID:28628823 ] [10.1016/j.ejmech.2017.06.005 ]